US pharma, Brazilian IP groups differ on US tariff response
By Nick Robertson ( July 8, 2026, 19:52 GMT | Insight) -- Organizations representing the American pharmaceutical industry and IP policy groups encouraged the Office of the US Trade Representative this week to move forward with punitive action against Brazil following a Section 301 investigation, while Brazilian groups denied claims of discriminatory conduct against the US.US pharmaceutical and industry groups urged the Office of the US Trade Representative this week to continue with plans to take punitive action against Brazil, after the office conducted a trade investigation and found Brazil's policies actionable as unfair trade practices....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.